Table 1.

CI for the combination of mitomycin C and bortezomib under hypoxia (1% O₂) was calculated using the CompuSyn software for LS174T and LS180 cancer cells

Combination therapy		CI
Mitomycin C (μg/mL)	Bortezomib (nmol/L)	LS174T	LS180
2	10	0.24^b	0.25^b
4	20	0.41^c	0.33^c
10	30	0.47^c	0.41^c

↵^aSlight synergy.
^bStrong synergy.
↵^cModerate synergy.